The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
High Morbidity and Mortality in Adults Hospitalized for Respiratory Syncytial Virus Infections
Abstract
BACKGROUND: Better understanding of complications and outcomes of adults hospitalized with respiratory syncytial virus (RSV) infection is necessary. METHODS: A retrospective cohort study was conducted on all adults (≥ 18 years) admitted to 3 acute care general hospitals in Hong Kong with virologically confirmed RSV infection during 2009-2011 (N = 607). Adults hospitalized for seasonal influenza during the period were used for comparison (n = 547). Both infections were prospectively diagnosed following a standard protocol. Independent reviews of chest radiographs were performed by radiologists. Main outcome measures were all-cause death, respiratory failure requiring ventilatory support, and hospitalization duration. Cox proportional hazards models were used for analyses. RESULTS: The mean age of RSV patients was 75 (SD, 16) years; 87% had underlying conditions. Lower respiratory and cardiovascular complications were diagnosed in 71.9% (pneumonia, 42.3%; acute bronchitis, 21.9%; chronic obstructive pulmonary disease/asthma exacerbation, 27.3%) and 14.3% of patients, respectively; 12.5% had bacterial superinfections. Supplemental oxygen and ventilatory support were required in 67.9% and 11.1%, respectively. Crude all-cause mortality was 9.1% and 11.9% within 30 days and 60 days, respectively; mean length of stay of survivors was 12 (SD, 13) days. Advanced age, radiographic pneumonia, requirement for ventilation, bacterial superinfection, and elevated urea level and white blood cell count were independently associated with poorer survival. Systemic corticosteroid use was associated with longer hospitalization and secondary infections. The overall outcomes of survival and length of stay were not significantly different from those in influenza. CONCLUSIONS: RSV can cause severe lower respiratory complications in older adults, resulting in respiratory failure, prolonged hospitalization, and high mortality similar to seasonal influenza. Corticosteroids did not seem to improve outcomes. The unmet need for antiviral therapy and vaccination against RSV in adults should be promptly addressed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nair, H., Nokes, D. J., Gessner, B. D., Dherani, M., Madhi, S. A., Singleton, R. J., O'Brien, K. L., Roca, A., Wright, P. F., Bruce, N., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60206-1 · Cited by 2,773 · cited 1×
“Respiratory syncytial virus (RSV) is known to be an important cause of lower respiratory tract infection in infants and young children, leading to hospitalizations and deaths [1].”
Respiratory Syncytial Virus Infection in Elderly and High-Risk Adults
Falsey, A. R., Hennessey, P. A., Formica, M. A., Cox, C., & Walsh, E. E. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043951 · Cited by 2,226
Viral Loads and Duration of Viral Shedding in Adult Patients Hospitalized with Influenza
Lee, N., Chan, P. K. S., Hui, D. S. C., Rainer, T. H., Wong, E., Choi, K., Lui, G. C. Y., Wong, B. C. K., Wong, R. Y. K., Lam, W., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/600383 · Cited by 526
Self-citationDeVincenzo, J., Lambkin-Williams, R., Wilkinson, T., Cehelsky, J., Nochur, S., Walsh, E., Meyers, R., Gollob, J., & Vaishnaw, A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912186107 · Cited by 442
Respiratory Syncytial Virus Infection in Adults
Falsey, A. R., & Walsh, E. E. (2000) · Clinical Microbiology Reviews · doi:10.1128/cmr.13.3.371 · Cited by 438
Glucocorticoids for acute viral bronchiolitis in infants and young children
Fernandes, R. M., Bialy, L. M., Vandermeer, B., Tjosvold, L., Plint, A. C., Patel, H., Johnson, D. W., Klassen, T. P., & Hartling, L. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004878.pub4 · Cited by 395
Widmer, K., Zhu, Y., Williams, J. V., Griffin, M. R., Edwards, K. M., & Talbot, H. K. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis309 · Cited by 364
Viral Infection in Patients with Severe Pneumonia Requiring Intensive Care Unit Admission
Choi, S.-H., Hong, S.-B., Ko, G.-B., Lee, Y., Park, H. J., Park, S.-Y., Moon, S. M., Cho, O.-H., Park, K.-H., Chong, Y. P., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201112-2240oc · Cited by 353
Viral Load Drives Disease in Humans Experimentally Infected with Respiratory Syncytial Virus
DeVincenzo, J. P., Wilkinson, T., Vaishnaw, A., Cehelsky, J., Meyers, R., Nochur, S., Harrison, L., Meeking, P., Mann, A., Moane, E., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201002-0221oc · Cited by 330
Lindsley, W. G., Blachere, F. M., Davis, K. A., Pearce, T. A., Fisher, M. A., Khakoo, R., Davis, S. M., Rogers, M. E., Thewlis, R. E., Posada, J. A., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/650457 · Cited by 217
Cited by
Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults
Papi, A., Ison, M. G., Langley, J. M., Lee, D.-G., Leroux-Roels, I., Martinon-Torres, F., Schwarz, T. F., van Zyl-Smit, R. N., Campora, L., Dezutter, N., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2209604 · Cited by 774
Respiratory Syncytial Virus: Infection, Detection, and New Options for Prevention and Treatment
Griffiths, C., Drews, S. J., & Marchant, D. J. (2017) · Clinical Microbiology Reviews · doi:10.1128/cmr.00010-16 · Cited by 586
Immunosenescence and human vaccine immune responses
Crooke, S. N., Ovsyannikova, I. G., Poland, G. A., & Kennedy, R. B. (2019) · Immunity & Ageing · doi:10.1186/s12979-019-0164-9 · Cited by 530
Ackerson, B., Tseng, H. F., Sy, L. S., Solano, Z., Slezak, J., Luo, Y., Fischetti, C. A., & Shinde, V. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy991 · Cited by 391
Off-season RSV epidemics in Australia after easing of COVID-19 restrictions
Eden, J.-S., Sikazwe, C., Xie, R., Deng, Y.-M., Sullivan, S. G., Michie, A., Levy, A., Cutmore, E., Blyth, C. C., Britton, P. N., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30485-3 · Cited by 340
Oral GS-5806 Activity in a Respiratory Syncytial Virus Challenge Study
DeVincenzo, J. P., Whitley, R. J., Mackman, R. L., Scaglioni-Weinlich, C., Harrison, L., Farrell, E., McBride, S., Lambkin-Williams, R., Jordan, R., Xin, Y., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1401184 · Cited by 339
Respiratory syncytial virus infection in adults
Nam, H. H., & Ison, M. G. (2019) · BMJ · doi:10.1136/bmj.l5021 · Cited by 332
Warren-Gash, C., Blackburn, R., Whitaker, H., McMenamin, J., & Hayward, A. C. (2018) · European Respiratory Journal · doi:10.1183/13993003.01794-2017 · Cited by 268
Metadata
- Authors
- Lee, N., Lui, G. C. Y., Wong, K. T., Li, T. C. M., Tse, E. C. M., Chan, J. Y. C., Yu, J., Wong, S. S. M., Choi, K. W., Wong, R. Y. K., Ngai, K. L. K., Hui, D. S. C., & Chan, P. K. S.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-07-21
- Volume
- 57
- Issue
- 8
- Pages
- 1069-1077
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2141475184
- Cited by
- 360
- References
- 32
- FWCI
- 14.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.